Do early premalignant changes in normal breast epithelial cells predict cancer development?
AffiliationCR-UK Department of Medical Oncology, University of Manchester, Christie Hospital NHS Trust, Manchester, UK.
MetadataShow full item record
AbstractA recent report suggests that, in an in vitro model of premalignant breast cells (vHMECs), silencing of INK4A gene is accompanied by over-expression of cyclo-oxygenase (COX)-2. This suggests that COX-2 over-expression may be an early event in breast cancer aetiology permitting clones within the normal epithelium to evade apoptosis, to increase their numbers and perhaps acquire further changes that promote the formation of hyperplasias, and eventually carcinomas. While COX-2 expression in normal breast epithelium in vivo has not been proven to be linked to an increased risk of breast cancer, its over-expression in the premalignant model in vitro does provide preliminary evidence that COX-2 inhibition may be a useful chemoprevention strategy.
CitationDo early premalignant changes in normal breast epithelial cells predict cancer development? 2005, 7 (1):18-20 Breast Cancer Res.
JournalBreast Cancer Research
- Hypermethylation of 14-3-3 sigma (stratifin) is an early event in breast cancer.
- Authors: Umbricht CB, Evron E, Gabrielson E, Ferguson A, Marks J, Sukumar S
- Issue date: 2001 Jun 7
- Up and downregulation of p16(Ink4a) expression in BRAF-mutated polyps/adenomas indicates a senescence barrier in the serrated route to colon cancer.
- Authors: Kriegl L, Neumann J, Vieth M, Greten FR, Reu S, Jung A, Kirchner T
- Issue date: 2011 Jul
- Morphologically normal-appearing mammary epithelial cells obtained from high-risk women exhibit methylation silencing of INK4a/ARF.
- Authors: Bean GR, Bryson AD, Pilie PG, Goldenberg V, Baker JC Jr, Ibarra C, Brander DM, Paisie C, Case NR, Gauthier M, Reynolds PA, Dietze E, Ostrander J, Scott V, Wilke LG, Yee L, Kimler BF, Fabian CJ, Zalles CM, Broadwater G, Tlsty TD, Seewaldt VL
- Issue date: 2007 Nov 15
- p38 regulates cyclooxygenase-2 in human mammary epithelial cells and is activated in premalignant tissue.
- Authors: Gauthier ML, Pickering CR, Miller CJ, Fordyce CA, Chew KL, Berman HK, Tlsty TD
- Issue date: 2005 Mar 1
- Mechanisms underlying the growth inhibitory effects of the cyclo-oxygenase-2 inhibitor celecoxib in human breast cancer cells.
- Authors: Basu GD, Pathangey LB, Tinder TL, Gendler SJ, Mukherjee P
- Issue date: 2005